Overcoming Barriers to Tobacco Cessation and Lung Cancer Screening among Racial and Ethnic Minority Groups and Underserved Patients in Academic Centers and Community Network Sites: The City of Hope Experience.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Presant Cary A, Ashing Kimlin, Raz Dan, Yeung Sophia, Gascon Brenda, Stewart Alexis, Macalintal Jonjon, Sandoval Argelia, Ehrunmwunsee Loretta, Phillips Tanyanika, Salgia Ravi, Merla Amartej, Subbiah Shanmuga, El-Hajjouie Michelle, Staley Jeffrey, Graves Heather, Pathak Ranjan, Dingal Shaira, Sampath Sagus, Laksana Beverly, Joseph Thomas, Eugenio Tricia, Degoma Veronica, Burns Kathleen, Phillips Sarah, Tan Tingting, Tarkshian Kelly, Sun Virginia, Amini Arya, Davy Khristie, Cronkhite Janet, Cianfrocca Mary, Brown Susan, Fong Yuman, Rosen Steven
Аннотация
METHODS: We performed a needs assessment. New tobacco control program services were implemented focusing on patients from racial and ethnic minority groups. Innovations included Whole Person Care with motivational counseling, placing clinician and nurse champions at points of care, training module and leadership newsletters, and a patient-centric personalized medicine Personalized Pathways to Success (PPS) program.
RESULTS: Emphasis on patients from racial and ethnic minority groups was implemented by training cessation personnel and lung cancer control champions. LDCT increased. Tobacco use assessment increased and abstinence was 27.2%. The PPS pilot program achieved 47% engagement in cessation, with self-reported abstinence at 3 months of 38%, with both results slightly higher in patients from racial and ethnic minority groups than in Caucasian patients.
CONCLUSIONS: Tobacco cessation barrier-focused innovations can result in increased lung cancer screening and tobacco cessation reach and effectiveness, especially among patients from racial and ethnic minority groups. The PPS program is promising as a personalized medicine patient-centric approach to cessation and lung cancer screening.